Iida Chie, Tatsumi Ako, Fujino Hisanori, Anzai Kaori, Sumimoto Shinichi
Pediatrics, Osaka Red Cross Hospital, Osaka, JPN.
Cureus. 2021 Jan 16;13(1):e12743. doi: 10.7759/cureus.12743.
Very early-onset inflammatory bowel disease (VEO-IBD) and infantile IBD occur in children aged less than six years and less than two years, respectively. Since childhood-onset IBD seems to be a more aggressive and rapidly progressive disease than adult-onset IBD, it should therefore be diagnosed and treated immediately. Here, we report a case of infantile IBD in a three-month-old infant with clinical and biochemical manifestations. The diagnosis was confirmed with histopathological evidence. The patient had been treated successfully with both mesalazine and prednisolone and with mesalazine alone on follow-up.
极早发型炎症性肠病（VEO-IBD）和婴儿型炎症性肠病分别发生在6岁以下和2岁以下的儿童中。由于儿童期发病的炎症性肠病似乎比成人期发病的炎症性肠病更具侵袭性且进展迅速，因此应立即进行诊断和治疗。在此，我们报告一例三个月大婴儿患婴儿型炎症性肠病的病例及其临床和生化表现。通过组织病理学证据确诊。该患者先后成功接受了美沙拉嗪和泼尼松龙联合治疗以及后续单独使用美沙拉嗪的治疗。
